Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ada King"'
Publikováno v:
Biochemistry. 56:6434-6447
Small molecules that modulate biological functions are targets of modern day drug discovery efforts. In a common platform fragment-based drug discovery, two fragments that bind to adjacent sites on a target are identified and are then linked together
Autor:
Dev P. Arya, Fenfei Leng, Weidong Wang, Nihar Ranjan, Yuk-Ching Tse-Dinh, Geraldine Fulcrand, Sandra Story, Souvik Sur, Ada King, Muzammil Ahmad
Publikováno v:
Journal of Medicinal Chemistry. 60:4904-4922
A series of Hoechst 33258 based mono- and bisbenzimidazoles have been synthesized and their Escherichia coli DNA topoisomerase I inhibition, binding to B-DNA duplex, and antibacterial activity has been evaluated. Bisbenzimidazoles with alkynyl side c
Autor:
Arren Z. Washington, Ada King, Derrick Watkins, Keith D. Green, Sylvie Garneau-Tsodikova, Yi Jin, Changjun Gong, Liuwei Jiang, Adegboyega K. Oyelere, Dev P. Arya
Publikováno v:
ACS Chemical Biology. 10:1278-1289
A 215-member mono- and diamino acid peptidic-aminosugar (PA) library, with neomycin as the model aminosugar, was systematically and rapidly synthesized via solid phase synthesis. Antibacterial activities of the PA library, on 13 bacterial strains (se
Autor:
Xiuping Jiang, Nihar Ranjan, Fenfei Leng, Geraldine Fulcrand, Dev P. Arya, Joseph C. Brown, Ada King
Publikováno v:
Med. Chem. Commun.. 5:816-825
Hoechst dyes are well known DNA binders that non-selectively inhibit the function of mammalian topoisomerase I and II. Herein, we show that Hoechst 33258 based bisbenzimidazoles (DPA 151–154), containing a terminal alkyne, are effective and selecti
Autor:
Dev P. Arya, Sunil Kumar, Changjun Gong, Nihar Ranjan, Ada King, Derrick Watkins, Jarred Whitlock
Publikováno v:
Antimicrobial agents and chemotherapy. 57(10)
We report here the affinity and antibacterial activity of a structurally similar class of neomycin dimers. The affinity of the dimer library for rRNA was established by using a screen that measures the displacement of fluorescein-neomycin (F-neo) pro